diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
199/11954
Phase 3 mab completed
Quick answer
diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis for Pertussis is a Phase 3 program (mab) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Pertussis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed